Edition:
United Kingdom

Galenica AG (GALE.S)

GALE.S on Swiss Exchange

48.86CHF
22 Mar 2019
Change (% chg)

CHF-0.54 (-1.09%)
Prev Close
CHF49.40
Open
CHF49.76
Day's High
CHF49.76
Day's Low
CHF48.70
Volume
117,260
Avg. Vol
145,685
52-wk High
CHF58.95
52-wk Low
CHF42.16

Summary

Name Age Since Current Position

Joerg Kneubuehler

58 2017 Chairman of the Board of Directors

Jean-Claude Clemencon

56 2017 Chief Executive Officer, Member of the Corporate Executive Committee, Head of Health & Beauty Segment

Felix Burkhard

52 2017 Chief Financial Officer, Member of the Corporate Executive Committee

Christoph Amstutz

55 2017 Member of the Corporate Executive Committee, Head Services Business Sector

Daniele Madonna

41 2017 Member of the Corporate Executive Committee, Head of Retail Business Sector

Thomas Szuran

2019 Member of the Corporate Executive Committee, Head of Products & Brands Sector

Daniela Bosshardt-Hengartner

46 2017 Member of the Board of Directors

Michel Burnier

65 2017 Member of the Board of Directors 

Fritz Hirsbrunner

69 2017 Member of the Board of Directors 

Bertrand Jungo

53 2018 Member of the Board of Directors

Philippe Nussbaumer

49 2017 Member of the Board of Directors 

Andreas Walde

56 2017 Member of the Board of Directors 

Biographies

Name Description

Joerg Kneubuehler

Dr. Joerg Kneubuehler has been Chairman of the Board of Directors of Galenica Ltd. since 2017. He joined the former Galenica Group in 2002 as Head of Finance and Administration at Vifor Pharma; was Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and Member of the Corporate Executive Committee from 2009; Chief Financial Officer from 2012 to 2016; and Chief Executive Officer Galenica Sante from 2014 to the first quarter of 2017. He held various positions in finance at the Swatch Group before joining Galenica. He has Ph.D. degree from the University of Bern.

Jean-Claude Clemencon

Mr. Jean-Claude Clemencon has been Chief Executive Officer, Member of the Corporate Executive Committee, Head of Health & Beauty Segment at Galenica Ltd. since 2017. He joined the Galenica Group in 1995 as Operations Manager Galexis Zurich; Head of Schoenbuehl Distribution Centre from 1999; Head of Galexis from 2002; Head Logistics Business sector from 2005 to 2015 and in addition in charge of HealthCare Information and Member of the Corporate Executive Committee of the Galenica Group from 2010; from 2015 to 2017 Head Retail Business sector and member of the Corporate Executive Committee of Galenica Sante. He is Member of the Board of Helvecura cooperative society (Bern). From 1988 to 1995 he was Head of Manufacturing at Rheintub AG (Rheinsulz) and Chief Executive Officer of Raintec GmbH, (Dogern, Germany). He has a degree in Logistics from sfb Technical College, Zurich and completed Program for Executive Development (PED) at IMD, Lausanne.

Felix Burkhard

Mr. Felix Burkhard has been Chief Financial Officer, Member of the Corporate Executive Committee at Galenica Ltd. since 2017. He joined the former Galenica Group in 1996 as Corporate Controller; Deputy Head Retail Business sector from 2000; in addition, Head of the Amavita pharmacy chain from 2008; Head Retail Business sector from 2010 to 2015; Member of the Corporate Executive Committee of Galenica Group since 2010 and he was Head Strategic Projects from 2015 to 2017. From 1991 to 1995 he was Financial Auditor at Revisuisse PriceWaterhouse (Bern) and Head of Finance and Controlling at Amidro (Biel-Bienne). He graduated from HSG University of St. Gallen (HSG) and is and Swiss certified accountant.

Christoph Amstutz

Mr. Christoph Amstutz has been Member of the Corporate Executive Committee, Head Services Business Sector at Galenica Ltd. since 2017. He has been Head Services Business Sector since 2015. He attended partial studies in pharmacy at the Federal Institute of Technology, Zurich (ETHZ) and has a degree in Marketing Management from the University of Bern. From 1988 to 2004 he was medical representative and product manager at UCB-Pharma AG (Zurich); Head of Marketing at UCB-Pharma GmbH (Kerpen, Germany); General Manager at UCB-Pharma AG (Zurich). Between 2004 and 2007 he served as Business Unit Manager CNS / Pain and Member of the Executive Board at Bristol-Myers Squibb GmbH (Baar) and from 2007 to 2010 he was Chief Executive Officer of Globopharm AG (Egg/Zurich). From 2010 until 2011 he served as Head of G-Pharma AG and in 2011 he was appointed Head of Alloga Ltd.

Daniele Madonna

Mr. Daniele Madonna has been Member of the Corporate Executive Committee, Head of Retail Business Sector at Galenica Ltd. since December 2017. He joined the former Galenica Group in 2004 as Manager of the Coop Vitality pharmacy in Tenero; Regional Sales Manager at Coop Vitality from 2010 to 2014; and Chief Executive Officer of Coop Vitality AG in Bern from 2014 to 2017. From 2003 to 2004 he was a Pharmacist at the Olympia Pharmacy and the Victoria Pharmacy in Zurich. He has a Federal Diploma in Pharmacy from the Federal Institute of Technology, Zurich (ETHZ), Professional training FPH in Retail Pharmacy and CAS in General Management at HSG (University of St Gallen) and Program for Executive Development (PED) at IMD Lausanne.

Thomas Szuran

Daniela Bosshardt-Hengartner

Ms. Daniela Bosshardt-Hengartner has been Member of the Board of Directors of Galenica Ltd. since 2017. She is Chairman of the Remuneration Committee and Member of the Audit and Risk Committee at the Company. She is a Pharmacist and has a Federal Diploma in Pharmacy from the Federal Institute of Technology, Zurich (ETHZ). She was Financial analyst at Bank am Bellevue (1998–2002) and M2 Capital (2003–2004), a Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004. She is Member of the Board of Directors of RepRisk AG (Zurich), Vifor Pharma Ltd. (Zurich) and investiere.ch (Baar).

Michel Burnier

Prof. Dr. Michel Burnier has been Member of the Board of Directors of Galenica Ltd. since 2017. He is Member of the Remuneration Committee at the Company. He is a Swiss-registered Doctor of Internal Medicine and Nephrology and has been a Lecturer at Universite de Lausanne. He has been Member of the following organizations: Swiss Society of Nephrology (former President), European Society of Hypertension (council member and Treasurer) and Swiss Society of Hypertension (former President). Formerly he was Member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001) and the Board of Swissmedic (2002–2010). He served as Member of the Board of Directors of Speedel Holding Ltd. (Basel) from 2007 to 2009. He is Member of the Board of Directors of Vifor Pharma Ltd. (Zurich).

Fritz Hirsbrunner

Mr. Fritz Hirsbrunner has been Member of the Board of Directors of Galenica Ltd. since 2017. He is Member of the Remuneration Committee and the Audit and Risk Committee at the Company. He graduated from HEC University of Lausanne and completed Senior Executive Program at IMD, Lausanne. From 1972 to 1977 he was Controller at Ciba-Geigy. He joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; Member of the Corporate Executive Committee from 1992 to 2011; Deputy Chief Executive Officer and Chief Financial Officer; Head Investor Relations until 2014. He has been Member of the Board of Trustees of IST Investmentstiftung fur Personalvorsorge (Zurich), Member of the Board of Directors of Berlac AG (Sissach), IVF Hartmann Holding AG (Neuhausen), VenCap 6 Ltd. (Jersey) and Vifor Pharma Ltd. (Zurich).

Bertrand Jungo

Mr. Bertrand Jungo has been Member of the Board of Directors of Galenica Ltd. since 2018. He has a Management degree from the University of Freiburg. From 2006 to 2017 he was Chief Executive Officer of the department store group Manor, beforehand held various management positions during 10 years at Manor. Since 2017 he has been Chief Executive Officer of Admeira Ltd. He is Advisory Board Member of the International Retail Summit (Gottlieb Duttweiler Institute,GDI).

Philippe Nussbaumer

Dr. Philippe Nussbaumer has been Member of the Board of Directors of Galenica Ltd. since 2017. He is a Pharmacist. He has a Federal Diploma and a Ph.D. in Pharmaceutical Sciences from University of Geneva, a dipl. oec. from HEC, University of Lausanne. He also has a Federal Ski Instructor Diploma and Federal Expert J+S. Since 2004 he has been Vice-President of the Swiss Snowsports School of Neuchatel / Les Bugnenets. He is owner and President of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds. Since 2007 he has been founder and administrator of Ecopharma pharmacy brand. Since 2014 he has been owner and president of the Medi-Centre Ltd. medical centre in La Chaux-de-Fonds. Since 2012 he has been Member of the Board of Directors of Veripharm Ltd.

Andreas Walde

Dr. Andreas Walde has been Member of the Board of Directors of Galenica Ltd. since 2017. He is Chairman of the Audit and Risk Committee at the Company. He is Attorney-at-law and holds doctorate in law from the University of Basel. He held various legal and management positions in the chemical and pharmaceutical industry for more than 25 years with specialization in financial and corporate structures, M&A, Risk Management, Compliance and Corporate Governance: 1988–1996 at Roche, 1998–2010 at Clariant and 2012–2013 at Petroplus, in the latter two among other as group general counsel; General Secretary of Vifor Pharma Ltd. (Zurich), former Galenica Group since 2013. His former positions include memberships on the Board of several private (non-Swiss) public listed companies as well as Member of the Board of the Society of Swiss Enterprises in Germany. He has been Member of the Board of SwissHoldings, the Federation of Industrial and Service Groups in Switzerland.